|
End-of-day quote
Buenos Aires S.E.
28/09/2026
|
5-day change | 1st Jan Change | ||
| 1,440.00 ARS | -4.64% |
|
-7.69% | -27.09% |
| Market Cap | 12TCr 7.63Cr 6.71Cr 6.34Cr 5.75Cr 11Cr 732.08Cr 11Cr 76Cr 29Cr 373.57Cr 29Cr 28Cr 1.2TCr | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 35TCr 23Cr 20Cr 19Cr 17Cr 32Cr 2.19TCr 32Cr 226.83Cr 88Cr 1.12TCr 86Cr 84Cr 3.59TCr | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -4.64% | ||
| 1 week | -7.69% | ||
| Current month | -10.56% | ||
| 1 month | -8.28% | ||
| 3 months | -10.00% | ||
| 6 months | -11.66% | ||
| Current year | -27.09% |
| 1 week | 1,360 | 1,590 | |
| 1 month | 1,360 | 1,635 | |
| Current year | 1,360 | 2,130 | |
| 1 year | 975 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.64% | -7.69% | +39.81% | +187.43% | 7.63Cr | ||
| +0.11% | +1.71% | +63.52% | +117.61% | 1,05600Cr | ||
| +0.27% | +0.92% | +51.33% | +73.35% | 66TCr | ||
| +0.73% | +0.68% | +20.70% | +74.90% | 47TCr | ||
| -0.77% | -3.16% | +37.68% | +40.79% | 34TCr | ||
| +0.08% | +4.33% | +22.67% | +29.43% | 28TCr | ||
| +1.59% | +0.35% | +14.68% | +14.54% | 26TCr | ||
| +0.85% | +6.35% | +53.17% | +54.39% | 23TCr | ||
| +0.85% | +1.10% | +35.78% | +101.82% | 19TCr | ||
| -0.09% | -2.76% | -28.41% | -60.92% | 17TCr | ||
| Average | -0.19% | +0.02% | +31.09% | +63.33% | 36.43TCr | |
| Weighted average by Cap. | +0.07% | +1.04% | +40.45% | +69.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.18TCr 6.02Cr 5.3Cr 5.01Cr 4.54Cr 8.53Cr 577.91Cr 8.58Cr 60Cr 23Cr 294.9Cr 23Cr 22Cr 947.64Cr | 13TCr 8.31Cr 7.31Cr 6.91Cr 6.27Cr 12Cr 797.84Cr 12Cr 83Cr 32Cr 407.12Cr 31Cr 31Cr 1.31TCr |
| Net income | 2.38TCr 1.56Cr 1.38Cr 1.3Cr 1.18Cr 2.22Cr 150.12Cr 2.23Cr 16Cr 6.01Cr 77Cr 5.87Cr 5.74Cr 246.17Cr | 308.78Cr 20.25L 17.81L 16.84L 15.28L 28.69L 19Cr 28.86L 2.02Cr 77.89L 9.92Cr 76.03L 74.39L 32Cr |
| Net Debt | 13TCr 8.77Cr 7.71Cr 7.29Cr 6.61Cr 12Cr 841.41Cr 12Cr 87Cr 34Cr 429.35Cr 33Cr 32Cr 1.38TCr | 23TCr 15Cr 13Cr 13Cr 11Cr 21Cr 1.45TCr 22Cr 150.89Cr 58Cr 742.22Cr 57Cr 56Cr 2.39TCr |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | ARS 1,440.00 | -4.64% | 5,318 |
| 25/26/25 | ARS 1,510.00 | 0.00% | 2,196 |
| 24/26/24 | ARS 1,510.00 | -0.66% | 10,447 |
| 23/26/23 | ARS 1,520.00 | -3.49% | 7,769 |
| 22/26/22 | ARS 1,575.00 | +0.96% | 349 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















